All Type of News
Detailed plan has yet to be finalized: KPA
The Korean Pharmaceutical Association said Thursday that its members will agree on sales of the so-called over-the-counter drugs at 24-hour convenient stores, re-emphasizing that the detailed plan has not yet to be fu...
Doctors under fire over illegal rebate practices
Thirteen health industry interest groups on Wednesday pledged to shrug off the long-standing illegal rebate practice in drug trade and set the market order straight.
However, the Korean Medical Association, the la...
KFDA to advocate “national health security”
The Korea Food and Administration unveiled its 2012 plan to approach food safety from the standpoint of “national health security.''
The KFDA is taking all efforts to ensure food safety as it is important to drive ...
Some drugmakers seeking to make opposition against drug price cut plan
Some Korean drug firms are poised to make an opposition against the government’s policy to slash drug prices next year amid the planned lawsuit led by the Korea Pharmaceutical Manufacturers Association.
More recent...
Patent court against Schering in patent suit
Korea’s patent court on Thursday dismissed claims by Schering-Plough Inc. in a patent lawsuit against two local drug firms of Ildong and Hanlim over their Nasonex (mometasone furoate) nasal spray, a treatment for alle...
Zuellig to help strengthen Korean drug firms’ presence in overseas markets
Zuellig Pharma Korea is planning to support Korean drug makers’ advancement into Asian pharmaceutical markets through Zuellig’s global logistics network, according to Christophe Piganiol, president of Zuellig Pharma K...
Tarceva set for first line treatment
Roche’s oral lung cancer treatment Tarceva (erlotinib) has been approved by the Korea Food and Drug Administration as a first line treatment for people with newly diagnosed advanced non-small cell lung cancer (NSCLC) ...
Korean scientists identifies cause for unknown gene fusion in lung cancer
Korean scientists have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-smokers, and might serve as a target for new therapies.
A team of r...
Fierce competition to be seen for erectile dysfunction drugs
With Korea’s third erectile dysfunction drug emerging in the market in October, other local companies are hoping U.S.-based Pfizer proves powerless to resist the stiffer competition as its Viagra patent is due to expi...
Drug makers to file suit against health ministry
A joint lawsuit of pharmaceutical firms seeking the suspension of the government plan to slash insurance drug prices will be filed with a court in next March, according to the Korea Pharmaceutical Manufacturer Associa...
